文献速递类风湿关节炎

IL18RAP基因表达与类风湿关节炎治疗反应相关

Investigation of genetically regulated gene expression and response to treatment in rheumatoid arthritis highlights an association between IL18RAP expression and treatment response.
PubMed 文献 · Ann Rheum Dis · 2020-07-30

研究纳入3158例欧洲血统类风湿关节炎患者,用PrediXcan预测基因表达并检验其与抗TNF治疗反应(ESR变化)的关联。IL18RAP预测表达在各参考面板中均显示与治疗反应相关的一致信号;在独立重复数据集中,全血IL18RAP表达与基线与随访间ESR变化相关(r=-0.35,p=0.0091),滑膜组织IL18RAP表达亦与ESR变化相关(r=-0.28,p=0.02)。

要点

  • IL18RAP预测表达在各参考面板中与抗TNF治疗反应呈一致关联信号。
  • 独立重复集中全血IL18RAP表达与ESR变化相关(r=-0.35,p=0.0091)。
  • 滑膜组织IL18RAP表达亦与ESR变化相关(r=-0.28,p=0.02)。

核心结论

  • IL18RAP表达值得进一步研究,可能作为类风湿关节炎治疗反应的预测指标,且不特定于某一药物类型。

研究设计与样本

  • 研究纳入3158例欧洲血统类风湿关节炎患者,并在1575例英国患者亚队列中分析。
  • 使用PrediXcan软件包与三种不同参考面板估计基因表达的遗传调控部分。
  • 以接受传统合成改善病情抗风湿药且经RNA测序直接测定基因表达的独立重复数据集,检验ESR变化与IL18RAP表达的相关性。

主要发现

  • IL18RAP预测表达在各参考面板中均显示与治疗反应相关的一致信号。
  • 独立重复数据集中,全血IL18RAP表达与基线与随访间ESR变化相关(r=-0.35,p=0.0091)。
  • 滑膜组织IL18RAP表达与ESR变化相关(r=-0.28,p=0.02)。

关键数值与推荐

  • 抗TNF治疗反应以ESR变化评估。
  • 全血IL18RAP表达与ESR变化的相关系数r=-0.35,p=0.0091。
  • 滑膜组织IL18RAP表达与ESR变化的相关系数r=-0.28,p=0.02。

临床怎么用

  • IL18RAP表达有望作为类风湿关节炎治疗反应的候选预测标志物,但尚需进一步研究验证。
  • 该信号不特定于某一药物类型,提示其可能跨治疗类别适用。

局限性

  • 原文摘要未报告预测表达与治疗反应关联的具体效应量与统计学阈值。
  • 重复验证数据来自接受传统合成改善病情抗风湿药的患者,非抗TNF治疗人群。
  • 原文摘要未报告研究的其他方法学局限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: In this study, we sought to investigate whether there was any association between genetically regulated gene expression (as predicted using various reference panels) and anti-tumour necrosis factor (anti-TNF) treatment response (change in erythrocyte sedimentation rate (ESR)) using 3158 European ancestry patients with rheumatoid arthritis. METHODS: The genetically regulated portion of gene expression was estimated in the full cohort of 3158 subjects (as well as within a subcohort consisting of 1575 UK patients) using the PrediXcan software package with three different reference panels. Estimated expression was tested for association with anti-TNF treatment response. As a replication/validation experiment, we also investigated the correlation between change in ESR with measured gene expression at the Interleukin 18 Receptor Accessory Protein (IL18RAP) gene in whole blood and synovial tissue, using an independent replication data set of patients receiving conventional synthetic disease modifying anti-rheumatic drugs, with directly measured (via RNA sequencing) gene expression. RESULTS: We found that predicted expression of IL18RAP showed a consistent signal of association with treatment response across the reference panels. In our independent replication data set, IL18RAP expression in whole blood showed correlation with the change in ESR between baseline and follow-up (r=-0.35, p=0.0091). Change in ESR was also correlated with the expression of IL18RAP in synovial tissue (r=-0.28, p=0.02). CONCLUSION: Our results suggest that IL18RAP expression is worthy of further investigation as a potential predictor of treatment response in rheumatoid arthritis that is not specific to a particular drug type.

来源:Ann Rheum Dis,查看原文。版权归原作者所有。

引用

  1. Cherlin S, Lewis MJ, Plant D, et al. Investigation of genetically regulated gene expression and response to treatment in rheumatoid arthritis highlights an association between IL18RAP expression and treatment response. Ann Rheum Dis. 2020. PMID: 32732242. doi:10.1136/annrheumdis-2020-217204

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。